How can you invest in a CarT drug biotech and still be asking questions about if there is a market for it? Wouldn't you think about that before pressing buy?
How many CarT drugs are on the market? What are their yearly sales. Try that in google. You are welcome.
Sort of like saying the oppies should have been used instead of the CR, without realising there were not enough oppies due the huge shortfall.
This is still a risky investment. But that CR has reduced that risk a lot.
Add to My Watchlist
What is My Watchlist?
